Headquartered in Chicago, IL Fiscal year ends December NASDAQ: GEHC gehealthcare.com
GE HealthCare Technologies Inc. is a global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions that help clinicians diagnose and treat complex diseases. The company operates through three segments: Advanced Imaging Solutions (encompassing MRI, CT, molecular imaging, X-ray, and ultrasound systems), Pharmaceutical Diagnostics (contrast agents and molecular imaging tracers used in diagnostic imaging procedures), and Patient Care Solutions (patient monitoring, anesthesia delivery, respiratory care, and related consumables and services). GE HealthCare serves hospitals, outpatient facilities, and research institutions worldwide, with approximately 54,000 employees and annual revenues of approximately $20.6 billion. The company is investing in theranostics, AI-powered clinical and operational tools, and radiopharmaceutical supply capabilities, including the pending acquisition of SOFIE Biosciences to establish a U.S. PET radiopharmaceutical distribution footprint. Updated
The segment investors had flagged as the weak link, Patient Care Solutions, expanded EBIT margin 480 basis points to 8.6%. That turnaround backs the raised full-year adjusted EPS guidance.
GE HealthCare reports before the open at 6:20 AM ET with analysts looking for $1.20 in EPS on $5.35 billion in revenue. Imaging demand and China exposure decide whether the April miss was a blip or the start of something.
Concentrix leads today's payouts with $22.6 million going to shareholders on November 3, at 37 cents a share. Four more companies, including GE HealthCare and Coca-Cola Consolidated, round out roughly $79 million in cash heading out the door over the next three weeks.
Jim Cramer went on live television and called out one of investing's most sacred rules, and the morning's earnings reports gave him some uncomfortable ammunition to work with.
Pre-Market Stock Futures: Futures are trading lower as today’s oil and interest rates are higher. Baseball legend Babe Ruth was often credited with the saying, “Records are made to be broken,” and…
Pre-Market Stock Futures: Futures are trading mixed after another tough day across Wall Street, with all the major indices crushed early on, before the Nasdaq made a late-afternoon push to wind up…
Pre-Market Stock Futures: Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday. We may start to see some end-of-the-quarter…
Pre-Market Stock Futures: Futures are trading lower after a strong mid-week rally that saw all major indices close 1% or higher, following three consecutive ominous days. However, Walmart issued worse-than-expected guidance, and…
GE HealthCare (NASDAQ: GEHC | GEHC Price Prediction) currently trades at $59.49, well below the Wall Street consensus price target of $89.74. That implies upside of roughly 50.8% if the analysts are…
Trey Thoelcke Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices except the Nasdaq end lower, with the Nasdaq closing virtually unchanged at…
The family of companies spun out from General Electric represents one of the most consequential industrial breakups in modern history. What was once a single conglomerate now trades as three distinct public…
Pre-Market Stock Futures: Futures are trading mostly higher after another risk-off day on Wall Street on Wednesday. Despite more solid news on the inflation front, as the producer price index report came…
Live Updates Wednesday Wrap-up4:13pm ETThe Vanguard S&P 500 ETF closed Wednesday at 583.12, down 0.1%. 25% Tariffs on India1:05pm ETIn a return of tariffs news to the headlines, President Trump just announced…
Live Updates Close, But No Cigar4:06pm ETWell, the S&P 500 gave it the ol’ college try, but ultimately came up short. After nine straight days of up markets, a 20-year record, the…
Stock spinoffs are a popular corporate strategy for unlocking shareholder value, but one that rarely pays off for investors. Harvard Business Review found half of all spinoffs failed to create any new…
The old investing adage that you can’t beat the market so just buy index funds misses the point. Warren Buffett, Peter Lynch, and a host of other money managers prove you can…
Back in 2021, General Electric (NYSE: GE | GE Price Prediction) announced the final step in a restructuring process that had begun in 2015. Deciding to streamline the company in an attempt…
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
GE HealthCare Technologies Inc. is a global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions that help clinicians diagnose and treat complex diseases.
24/7 Wall St.'s 12-month price target for GEHC is $88.78, rated Buy. The Wall Street consensus target is $82.70. GEHC price prediction →
